Re: FDA, CDER Data Standards Plan

2010-07-16 Thread Andersson, Bo H
Hi Susie and Scott, This looks like an opportunity we can't miss. HCLS have a lot of experience with Semantic Web to feed back to FDA in their work with the CEDER standard plan. Kerstin and I are interested to contribute with our experience when HCLS review the plan and provide feedback.

TMO: Please provide feedback on User Interaction Storyboard

2010-03-26 Thread Andersson, Bo H
Hi, To be able to progress the work with the TMO - user interface/interaction we need your feedback on the storyboard. TMO-UI wiki: http://esw.w3.org/HCLSIG/PharmaOntology/Interface Storyboard: http://esw.w3.org/images/9/9b/HCLSIG%24%24PharmaOntology%24%24Interface% 24translational_ontol

RE: LODD Telcon

2009-07-08 Thread Andersson, Bo H
Webex details for Demo of the Linked Data application: We invites you to attend this online meeting. Topic: Demo of Linked Data application Date: Wednesday, July 8, 2009 Time: 5:00 pm, Europe Daylight Time (GMT +02:00, Paris ) Meeting Number: 684 608 308 Meeting Password: lodd Please click

LarKC presentation for HCLS

2008-12-11 Thread Andersson, Bo H
Dear all, We will use WebEx for a demonstration when we present LarKC in today's call. The presentation will be available at the HCLS wiki. LinkedLifeData is available at http://www.LinkedLifeData.com . If you experience problems connection to WebEx. Backup page for LLD: http://www.ontotext.com

RE: HCLS F2F

2008-08-29 Thread Andersson, Bo H
Susie, I propose a small change in the agenda. As some of the tasks have hardly started I believe we need more time to work FtF in the task groups. My proposal is to split the three hour slot on Monday into two, where the two first hours are used for task break out sessions. Like this: Monda

RE: [BIONT-DSE] Clinical Observations Interoperability Telcon September 11th, Tuesday 11:00am - 12:00pm US EDT

2007-09-10 Thread Andersson, Bo H
Dear Rachel and Landen, Following up from the Clinical Observations Interoperability Telcon two weeks ago, I do think your presentations where very interesting. From my perspective working in early clinical development within AstraZeneca I do think